LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Home・Listă Acțiuni・Dynavax Technologies Corp

Dynavax Technologies Corp

Închisă

SectorSănătate

10.88 -0.73

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

10.84

Maxim

11.1

Indicatori cheie
By Trading Economics
Venit	8.2M 27M
Vânzări	-566K 95M
P/E Medie Sector	58.75 80.03
Marjă de profit	28.381
Angajați	405
EBITDA	7M 32M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+86.87% upside

Statistici piață
By TradingEconomics
Capitalizare de piață	63M 1.3B
Deschiderea anterioară	11.61
Închiderea anterioară	10.88

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

9.62 / 10.9 Suport & Rezistență

Dynavax Technologies Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 dec. 2025, 22:13 UTC

Câștiguri

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

9 dec. 2025, 21:40 UTC

Câștiguri

GameStop Sales Fall as Collectibles Remain Only Bright Spot

9 dec. 2025, 18:51 UTC

Achiziții, Fuziuni, Preluări

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec. 2025, 16:57 UTC

Principalele dinamici ale pieței

Clear Secure Rises on Medicare Identity Verification Contract

9 dec. 2025, 23:46 UTC

Market Talk

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

9 dec. 2025, 23:46 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings Stake in Lenovo Now at 32.34%

9 dec. 2025, 23:45 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

9 dec. 2025, 23:44 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

9 dec. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

9 dec. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

9 dec. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

9 dec. 2025, 22:42 UTC

Câștiguri

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

9 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 dec. 2025, 21:48 UTC

Market Talk

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

9 dec. 2025, 20:28 UTC

Market Talk

Oil Futures Decline for Second Straight Session -- Market Talk

9 dec. 2025, 20:27 UTC

Achiziții, Fuziuni, Preluări

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

9 dec. 2025, 20:27 UTC

Achiziții, Fuziuni, Preluări

Teck Reports Voting Results From Special Meeting of Hldrs

9 dec. 2025, 20:26 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

9 dec. 2025, 20:21 UTC

Market Talk

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

9 dec. 2025, 19:52 UTC

Câștiguri

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

9 dec. 2025, 19:17 UTC

Câștiguri

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

9 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 dec. 2025, 17:11 UTC

Câștiguri

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Comparație

Modificare preț

Dynavax Technologies Corp Așteptări

Obiectiv de preț

By TipRanks

86.87% sus

Prognoză pe 12 luni

Medie 20.5 USD 86.87%

Maxim 25 USD

Minim 16 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDynavax Technologies Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

3 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 3 analiști care au acordat evaluări ale acțiunilor Dynavax Technologies Corp - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

9.62 / 10.9Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bearish.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.